| For: | Okano K, Kakinoki K, Akamoto S, Hagiike M, Usuki H, Yamamoto Y, Nishiyama Y, Suzuki Y. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer. World J Gastroenterol 2011; 17(2): 231-235 [PMID: 21245997 DOI: 10.3748/wjg.v17.i2.231] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i2/231.htm |
| Number | Citing Articles |
| 1 |
Daniel Ansari, Inger Keussen, Roland Andersson. Positron emission tomography in malignancies of the liver, pancreas and biliary tract – indications and potential pitfalls. Scandinavian Journal of Gastroenterology 2013; 48(3) doi: 10.3109/00365521.2012.704936
|
| 2 |
Ameya D. Puranik, Archi Agrawal, Sneha Shah, Nilendu Purandare, Venkatesh Rangarajan. PET/CT in Hepatobiliary and Pancreatic Malignancies. 2018; doi: 10.1007/978-3-319-60507-4_7
|
| 3 |
Asahi Sato, Toshihiko Masui, Akitada Yogo, Yuichiro Uchida, Kenzo Nakano, Takayuki Anazawa, Kazuyuki Nagai, Kyoichi Takaori, Yuji Nakamoto, Shinji Uemoto. Usefulness of 18F‐FDG‐PET/CT in the diagnosis and prediction of recurrence of pancreatic neuroendocrine neoplasms. Journal of Hepato-Biliary-Pancreatic Sciences 2020; 27(7) doi: 10.1002/jhbp.734
|
| 4 |
Priyanka Jha, Bijan Bijan, Giselle Melendres, David K. Shelton. Hybrid Imaging for Pancreatic Malignancy. Clinical Nuclear Medicine 2015; 40(3) doi: 10.1097/RLU.0000000000000677
|
| 5 |
Sampath Santhosh, Bhagwant R. Mittal, Deepak Bhasin, Surinder S. Rana, Anish Bhattacharya, Radhika Srinivasan, Ritambhra Nada, Rajesh Gupta. Dual-phase 18F-FDG PET/CT imaging in the characterization of pancreatic lesions. Nuclear Medicine Communications 2014; 35(10) doi: 10.1097/MNM.0000000000000157
|
| 6 |
Alan R. Penheiter, Sibel Erdogan, Stephen J. Murphy, Steven N. Hart, Joema Felipe Lima, Fariborz Rakhshan Rohakhtar, Daniel R. O’Brien, William R. Bamlet, Ryan E. Wuertz, Thomas C. Smyrk, Fergus J. Couch, George Vasmatzis, Claire E. Bender, Stephanie K. Carlson. Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma. BioMed Research International 2015; 2015 doi: 10.1155/2015/593572
|
| 7 |
Orazio Schillaci. Use of Dual-Point Fluorodeoxyglucose Imaging to Enhance Sensitivity and Specificity. Seminars in Nuclear Medicine 2012; 42(4) doi: 10.1053/j.semnuclmed.2012.02.003
|
| 8 |
Keiichi Okano, Hironobu Suto, Minoru Oshima, Yasuhisa Ando, Mina Nagao, Hideki Kamada, Hideki Kobara, Tsutomu Masaki, Hiroyuki Okuyama, Yoshihiro Okita, Akihito Tsuji, Yasuyuki Suzuki. 18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer. Japanese Journal of Clinical Oncology 2018; 48(5) doi: 10.1093/jjco/hyy033
|
| 9 |
Dushyant V. Sahani, Pietro A. Bonaffini, Onofrio A. Catalano, Alexander R. Guimaraes, Michael A. Blake. State-of-the-Art PET/CT of the Pancreas: Current Role and Emerging Indications. RadioGraphics 2012; 32(4) doi: 10.1148/rg.324115143
|
| 10 |
Hulya Wieshmann, K. N. Pannag Desai. Textbook of Pancreatic Cancer. 2021; doi: 10.1007/978-3-030-53786-9_36
|
| 11 |
Pratyusha Nunna, Sara Sheikhbahaei, Sejin Ahn, Brenda Young, Rathan M. Subramaniam. The Role of Positron Emission Tomography/Computed Tomography in Management and Prediction of Survival in Pancreatic Cancer. Journal of Computer Assisted Tomography 2016; 40(1) doi: 10.1097/RCT.0000000000000323
|
| 12 |
M. Wartski, R. Coriat, P.Y. Salaün. Cancers du pancréas. Médecine Nucléaire 2019; 43(1) doi: 10.1016/j.mednuc.2018.12.008
|
| 13 |
Masataka Kikuyama, Terumi Kamisawa, Sawako Kuruma, Kazuro Chiba, Shinya Kawaguchi, Shuzo Terada, Tatsunori Satoh. Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer. Cancers 2018; 10(2) doi: 10.3390/cancers10020048
|
| 14 |
Nadine Mallak, Thomas A. Hope, Alexander R. Guimaraes. PET/MR Imaging of the Pancreas. Magnetic Resonance Imaging Clinics of North America 2018; 26(3) doi: 10.1016/j.mric.2018.03.003
|
| 15 |
Shaunagh McDermott, Selim R. Butros, Michael A. Blake. Textbook of Gastrointestinal Radiology, 2-Volume Set. 2015; doi: 10.1016/B978-1-4557-5117-4.00068-4
|
| 16 |
Keiji Hanada, Akihito Okazaki, Naomichi Hirano, Yoshihiro Izumi, Yuji Teraoka, Juri Ikemoto, Kozue Kanemitsu, Fumiaki Hino, Toshikatsu Fukuda, Shuji Yonehara. Diagnostic strategies for early pancreatic cancer. Journal of Gastroenterology 2015; 50(2) doi: 10.1007/s00535-014-1026-z
|
| 17 |
Anna Maria De Gaetano, Vittoria Rufini, Paola Castaldi, Anna Maria Gatto, Laura Filograna, Alessandro Giordano, Lorenzo Bonomo. Clinical applications of 18F-FDG PET in the management of hepatobiliary and pancreatic tumors. Abdominal Imaging 2012; 37(6) doi: 10.1007/s00261-012-9845-y
|
| 18 |
Xuan Zhang, Zhiming Zeng, Huiyi Liu, Li Xu, Xin Sun, Jing Xu, Guosheng Song. Recent development of a magneto-optical nanoplatform for multimodality imaging of pancreatic ductal adenocarcinoma. Nanoscale 2022; 14(9) doi: 10.1039/D1NR08394E
|
| 19 |
Laura Brullé, Marc Vandamme, Delphine Riès, Eric Martel, Eric Robert, Stéphanie Lerondel, Valérie Trichet, Serge Richard, Jean-Michel Pouvesle, Alain Le Pape, Connie J. Eaves. Effects of a Non Thermal Plasma Treatment Alone or in Combination with Gemcitabine in a MIA PaCa2-luc Orthotopic Pancreatic Carcinoma Model. PLoS ONE 2012; 7(12) doi: 10.1371/journal.pone.0052653
|
| 20 |
Masayoshi Saito, Takeshi Ishihara, Motohisa Tada, Toshio Tsuyuguchi, Rintaro Mikata, Yuji Sakai, Katsunobu Tawada, Harutoshi Sugiyama, Jo Kurosawa, Masayuki Otsuka, Yoshitaka Uchida, Katsuhiro Uchiyama, Masaru Miyazaki, Osamu Yokosuka. Use of F-18 Fluorodeoxyglucose Positron Emission Tomography With Dual-Phase Imaging to Identify Intraductal Papillary Mucinous Neoplasm. Clinical Gastroenterology and Hepatology 2013; 11(2) doi: 10.1016/j.cgh.2012.10.037
|
| 21 |
Shunpei Kanai, Tomoaki Nakamura, Masaru Nagato, Masanobu Taniguchi, Ichiro Nakamura, Akira Kawaguchi, Takumi Shimomatsuya, Kazuhiro Maruhashi, Takashi Kusui, Haruhiko Maruyama. A Case of Obstructive Pancreatitis Caused by a Foreign Substance in the Main Pancreatic Duct in Which Differentiation from Pancreatic Cancer Was Difficult. The Japanese Journal of Gastroenterological Surgery 2014; 47(5) doi: 10.5833/jjgs.2013.0112
|
| 22 |
Keiji Hanada, Akihito Okazaki, Naomichi Hirano, Yoshihiro Izumi, Tomoyuki Minami, Juri Ikemoto, Kozue Kanemitsu, Fumiaki Hino. Effective screening for early diagnosis of pancreatic cancer. Best Practice & Research Clinical Gastroenterology 2015; 29(6) doi: 10.1016/j.bpg.2015.09.017
|
| 23 |
N. Ergul, C. Gundogan, M. Tozlu, H. Toprak, H. Kadıoglu, M. Aydin, T.F. Çermik. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in diagnosis and management of pancreatic cancer; comparison with Multidetector Row Computed Tomography, Magnetic Resonance Imaging and Endoscopic Ultrasonography. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2014; 33(3) doi: 10.1016/j.remnie.2014.03.016
|
| 24 |
Natsuko Kawada, Hiroyuki Uehara, Takuya Hosoki, Motohisa Takami, Hisakazu Shiroeda, Tomiyasu Arisawa, Yasuhiko Tomita. Usefulness of Dual-Phase 18F-FDG PET/CT for Diagnosing Small Pancreatic Tumors. Pancreas 2015; 44(4) doi: 10.1097/MPA.0000000000000313
|
| 25 |
Minoru Oshima, Keiichi Okano, Shinobu Muraki, Reiji Haba, Takashi Maeba, Yasuyuki Suzuki, Shinichi Yachida. Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer. Annals of Surgery 2013; 258(2) doi: 10.1097/SLA.0b013e3182827a65
|
| 26 |
Shigeki Nagamachi, Ryuichi Nishii, Hideyuki Wakamatsu, Youichi Mizutani, Shogo Kiyohara, Seigo Fujita, Shigemi Futami, Tatefumi Sakae, Eiji Furukoji, Shozo Tamura, Hideo Arita, Kazuo Chijiiwa, Keiichi Kawai. The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with 18F-FDG PET/CT. Annals of Nuclear Medicine 2013; 27(6) doi: 10.1007/s12149-013-0719-3
|
| 27 |
Erik V. Soloff, Atif Zaheer, Jeffrey Meier, Marc Zins, Eric P. Tamm. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease. Abdominal Radiology 2018; 43(2) doi: 10.1007/s00261-017-1410-2
|
| 28 |
P. Lovinfosse, R. Hustinx, O.-F. Couturier. TEP/TDM multi-phase : revue de la littérature. Médecine Nucléaire 2021; 45(2) doi: 10.1016/j.mednuc.2021.02.002
|
| 29 |
Pan Zhou. [99mTc]Tc-labeled cyc-DX600-HYNIC as a SPECT probe for ACE2-specific pancreatic cancer imaging. American Journal of Nuclear Medicine and Molecular Imaging 2024; 14(2) doi: 10.62347/VFHT4078
|
| 30 |
Khaled Y. Elbanna, Hyun-Jung Jang, Tae Kyoung Kim. Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review. Insights into Imaging 2020; 11(1) doi: 10.1186/s13244-020-00861-y
|
| 31 |
Coman Ionuţ Simion, Coman Elena Violeta , Florea Costin George , Tudose Teodora Elena , Burleanu Cosmin , Erchid Anwar , Grigorean Valentin Titus . Diagnostic Challenges in Pancreatic Tumors. IgMin Research 2024; 2(5) doi: 10.61927/igmin185
|
| 32 |
Mitsuyoshi Yoshimoto, Takuya Hayakawa, Michihiro Mutoh, Toshio Imai, Keisuke Tsuda, Sadaaki Kimura, Izumi O. Umeda, Hirofumi Fujii, Keiji Wakabayashi. In Vivo SPECT Imaging with 111In-DOTA-c(RGDfK) to Detect Early Pancreatic Cancer in a Hamster Pancreatic Carcinogenesis Model. Journal of Nuclear Medicine 2012; 53(5) doi: 10.2967/jnumed.111.099630
|
| 33 |
N. Ergul, C. Gundogan, M. Tozlu, H. Toprak, H. Kadıoglu, M. Aydin, T.F. Çermik. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in diagnosis and management of pancreatic cancer; comparison with Multidetector Row Computed Tomography, Magnetic Resonance Imaging and Endoscopic Ultrasonography. Revista Española de Medicina Nuclear e Imagen Molecular 2014; 33(3) doi: 10.1016/j.remn.2013.08.005
|
| 34 |
Lulu Zhang, Santosh Sanagapalli, Alina Stoita. Challenges in diagnosis of pancreatic cancer. World Journal of Gastroenterology 2018; 24(19): 2047-2060 doi: 10.3748/wjg.v24.i19.2047
|
| 35 |
Jian Zhang, Chang-Jing Zuo, Ning-Yang Jia, Jian-Hua Wang, Sheng-Ping Hu, Zhong-Fei Yu, Yuan Zheng, An-Yu Zhang, Xiao-Yuan Feng. Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer. World Journal of Gastroenterology 2015; 21(10): 2988-2996 doi: 10.3748/wjg.v21.i10.2988
|
| 36 |
Keiichi Okano, Yasuyuki Suzuki. Strategies for early detection of resectable pancreatic cancer. World Journal of Gastroenterology 2014; 20(32): 11230-11240 doi: 10.3748/wjg.v20.i32.11230
|
| 37 |
Kai Luo, Xiangkun Wang, Xudong Zhang, Zhongyuan Liu, Shuai Huang, Renfeng Li. The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.933645
|
| 38 |
Yutaka Okagawa, Tomohiro Kondo, Yasushi Tsuji, Toshizo Takayama, Shutaro Oiwa, Masahiro Yoshida, Hideyuki Ihara, Tetsuya Sumiyoshi, Michiaki Hirayama, Hitoshi Kondo. Natural History of Pancreatic Ductal Adenocarcinoma Diagnosed During Observation of Other Organ Cancers. American Journal of Case Reports 2019; 20 doi: 10.12659/AJCR.917197
|
| 39 |
Mingxing Wang, Yunyun Xu, Min Yang, Dingyi Jiang, Yunwang Chen, Jiahong Jiang, Zheling Chen, Liu Yang, Dongsheng Huang. Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.579239
|